The emerging approach of this peptide represents a exciting development in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide066066.activoblog.com/54171358/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment